Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 40.67 | -17.78 |
PEG Ratio (TTM) | 0.41 | -5.55 |
P/S Ratio (TTM) | N/A | 39.43 |
P/B Ratio (TTM) | 1.04 | 5.80 |
P/FCF Ratio (TTM) | -633.94 | -146.47 |
Price to 5YR AVG Earnings Ratio | N/A | -34.01 |
Price to 5YR AVG FCF Ratio | N/A | -1.00 |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 2.48% | 288.99% |
ROE (TTM) | 2.58% | -4,244.29% |
Net Profit Margin (TTM) | N/A | -1,050.76% |
ROIC 5YR AVG | N/A | -15.85% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -5,795.77% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -2,349.55% | N/A | N/A |
Cash Flow | -107.55% | N/A | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 37.04 | 4.94 |
Quick Ratio (TTM) | 37.04 | 4.92 |
D/E Ratio (TTM) | N/A | 1.30 |
Interest Coverage (TTM) | 0.28 | -11.46 |
Piotroski F-Score | 4 | 3 |
Altman Z-Score | N/A | 21.03 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 892.04% |